AST
Asterias Biotherapeutics Inc. Series A
AST
AST
Delisted
AST was delisted on the 7th of March, 2019.
62 hedge funds and large institutions have $13.3M invested in Asterias Biotherapeutics Inc. Series A in 2018 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
45% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 22
93% less call options, than puts
Call options by funds: $10K | Put options by funds: $148K
Holders
62
Holding in Top 10
1
Calls
$10K
Puts
$148K
Top Buyers
| 1 | +$663K | |
| 2 | +$201K | |
| 3 | +$194K | |
| 4 |
Renaissance Technologies
New York
|
+$142K |
| 5 |
LP
LMR Partners
London,
United Kingdom
|
+$110K |
Top Sellers
| 1 | -$1.49M | |
| 2 | -$525K | |
| 3 | -$343K | |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
-$121K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$117K |